Approaches to Treating Plaque Psoriasis
Expert dermatologists share how the understanding of the pathophysiology of plaque psoriasis guides approaches to therapy.
Source: hcplive.com
📰 Bruce Strober News
Page 2 - Bruce Strober News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bruce Strober. Real-time updates on events, politics, business and more.
Impact of Plaque Psoriasis on Quality of Life
Drs Bruce Strober, Benjamin Lockshin, and Jennifer Soung discuss how plaque psoriasis impacts a patient’s quality of life, focusing on patient-reported outcome measurements as well as special areas affected by plaque psoriasis.
Source: hcplive.com
Patient to inventor: How this psoriasis survivor helped invent a treatment drug | Health
Struggling with psoriasis since his teens, Ryan Moslin went on to become part of a team that invented a drug for the disease. Now his symptoms are improving. | Health
Source: hindustantimes.com
Wear The Gown: Battling stubborn plaque psoriasis
A new oral treatment is now available to combat the disease.
United States Nitika Chopra Bristol Myers Squibb Bruce Strober National Psoriasis Foundation Drug Administration
Source: kens5.com
Bristol Myers Squibb Launches Clear Understanding Campaign to Reveal the Plain Truth About Living with Moderate to Severe Plaque Psoriasis
PRINCETON, N.J.--(BUSINESS WIRE)--Aug 8, 2023--
United States Bristol Myers Squibb Bruce Strober Michael Braun Nitika Chopra National Psoriasis Foundation
Source: eagletribune.com
Subcutaneous Spesolimab Reduces GPP Flares: Phase 2 Study
For generalized pustular psoriasis, treatment with the subcutaneously administered IL-36 receptor antagonist resulted in a significant reduction in flares compared with placebo.
Source: medscape.com
Study Finds Spesolimab Helps Prevent Generalized Pustular Psoriasis Flares
New clinical trial data shows benefits of spesolimab for GPP flares, providing compelling evidence for IL-36 signaling’s effect on the condition’s pathogenesis.
Boehringer Ingelheim Bruce Strober Carinne Brouillon Dermatology At Yale University Drug Administration World Congress
Source: hcplive.com
Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL 2 trial
Today at the 25th World Congress of Dermatology WCD Boehringer Ingelheim presented new latebreaking data from the EFFISAYIL 2 trial showing that spesolimab significantly reduced the risk of GPP flares by 84 over 48 weeks compared to placebo.
Yale University United States Rheinland Pfalz Laura Lessenich Frida Dunger Johnsson Carinne Brouillon
Source: businesswireindia.com
Guselkumab Safety Profile Consistent for Psoriasis, PsA at 5 Years
An analysis of 11 late-stage clinical trials shows guselkumab provides a consistent and comparable safety profile to placebo in treated patients.
Yale University United States Bruce Strober Central Connecticut Dermatology Research Yale University School Of Medicine Clinical Rheumatology
Source: hcplive.com
Future Directions in the Use of TYK2 Inhibitors for the Treatment of Psoriasis
Linda Stein Gold, MD, and Bruce Strober, MD, PhD, review the clinical and practical impact of TYK2 inhibition and its evolving role within the treatment landscape for psoriatic disease.
Bruce Strober Linda Stein Gold Stein Gold Tyk2 Inhibitors Plaque Psoriasis Future Of Plaque Psoriasis Treatment
Source: hcplive.com